BANGI, Nov 1 — Datuk Seri Ismail Sabri Yaakob today launched the National Vaccine Development Roadmap (PPVN) and Malaysian Genome and Vaccine Institute (MGVI) in an effort to turn the country into a hub for vaccine production and boost confidence in vaccine use.
The prime minister said that through PPVN and MGVI, Malaysia could produce its own vaccines that are of quality, effective and safe in accordance with the conditions set by the National Pharmaceutical Regulatory Agency (NPRA).
“Although R&D and vaccine production require heavy investment, such efforts have the potential to bring long-term returns for Keluarga Malaysia (Malaysian Family) in the form of cost savings in treating diseases and investments by multinational companies in Malaysia.
“Through the implementation of PPVN and establishment of MGVI, highly skilled human capital in various fields of research especially those related to healthcare and vaccines can be produced,” he said at the launch ceremony at the Malaysian Genome Institute (MGI) here.
Also present were Science, Technology and Innovation Minister Datuk Seri Dr Adham Baba and Health Minister Khairy Jamaluddin. — Bernama